Systolic blood pressure reduction and risk of acute renal injury in patients with intracerebral hemorrhage

American Journal of Medicine

Volumn 125, Issue 7, 2012, Pages

  Qureshi, Adnan I ^a   Palesch, Yuko Y ^b   Martin, Renee ^b   Novitzke, Jill ^a   Cruz Flores, Salvador ^c   Ehtisham, Asad ^d   Goldstein, Joshua N ^e   Kirmani, Jawad F ^f   Hussein, Haitham M ^a   Suri, M Fareed K ^a   Tariq, Nauman ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c SAINT LOUIS UNIVERSITY   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f John F Kennedy Medical Center   (United States)

Author keywords

Acute hypertensive response; Acute renal injury; Calcium channel blocker; Intracerebral hemorrhage; Systolic blood pressure

Indexed keywords

CREATININE; NICARDIPINE;

ACUTE KIDNEY FAILURE; ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BRAIN HEMORRHAGE; CLINICAL TRIAL (TOPIC); CREATININE BLOOD LEVEL; FEMALE; FLUID THERAPY; HEMATOMA; HOSPITALIZATION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; POST HOC ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ACUTE KIDNEY INJURY; AGED; ANTIHYPERTENSIVE AGENTS; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; MALE; MIDDLE AGED; NICARDIPINE;

EID: 84862641604     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.09.031     Document Type: Article

References (27)

1. Ovbiagele B, Pineda S, Saver JL. Renal dysfunction and discharge destination in patients with intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2011;20:145-149.
2. Jivraj S, Mazer CD, Baker AJ, Choi M, Hare GM. Case report: profound hypotension associated with labetalol therapy in a patient with cerebral aneurysms and subarachnoid hemorrhage. Can J Anaesth. 2006;53:678-683.
3. Hankey GJ, Gubbay SS. Focal cerebral ischaemia and infarction due to antihypertensive therapy. Med J Aust. 1987;146:412-414.
4. Rodriguez GJ, Cordina SM, Vazquez G, et al. The hydration influence on the risk of stroke (THIRST) study. Neurocrit Care. 2009;10:187-194.
5. Qureshi AI. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation. 2008;118:176-187.
6. Hao Z, Wu B, Lin S, et al. Association between renal function and clinical outcome in patients with acute stroke. Eur Neurol. 2010;63: 237-242.
7. Tsagalis G, Akrivos T, Alevizaki M, et al. Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality. Nephrol Dial Transplant. 2009;24:194-200.
8. Oleinik A, Romero JM, Schwab K, et al. CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathy. Stroke. 2009;40:2393-2397.
9. Haley EC Jr, Kassell NF, Torner JC. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg. 1993;78:537-547.
10. Qureshi AI. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH): rationale and design. Neurocrit Care. 2007;6:56-66.
11. Anonymous. Antihypertensive treatment of acute cerebral hemorrhage. Crit Care Med. 2010;38:637-648.
12. Lopes JA, Fernandes P, Jorge S, et al. Acute kidney injury in intensive care unit patients: a comparison between the RIFLE and the Acute Kidney Injury Network classifications. Crit Care. 2008;12:R110.
13. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259-2264.
14. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343: 180-184.
15. Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000;36:1542-1548.
16. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.
17. Praught ML, Shlipak MG. Are small changes in serum creatinine an important risk factor? Curr Opin Nephrol Hypertens. 2005;14:265-270.
18. Lassnigg A, Schmid ER, Hiesmayr M, et al. Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure? Crit Care Med. 2008;36:1129-1137.
19. Qureshi AI, Harris-Lane P, Kirmani JF, et al. Treatment of acute hypertension in patients with intracerebral hemorrhage using American Heart Association guidelines. Crit Care Med. 2006;34:1975-1980.
20. Solenski NJ, Haley EC Jr, Kassell NF, et al. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med. 1995;23:1007-1017.
21. Wallin JD, Fletcher E, Ram CV, et al. Intravenous nicardipine for the treatment of severe hypertension. A double-blind, placebo-controlled multicenter trial. Arch Intern Med. 1989;149:2662-2669.
22. Aronson S, Dyke CM, Stierer KA, et al. The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg. 2008;107:1110-1121.
23. Aronson S. Clevidipine in the treatment of perioperative hypertension: assessing safety events in the ECLIPSE trials. Expert Rev Cardiovasc Ther. 2009;7:465-472.
24. Hayashi K, Nagahama T, Oka K, Epstein M, Saruta T. Disparate effects of calcium antagonists on renal microcirculation. Hypertens Res. 1996;19:31-36.
25. Baba T, Ishizaki T, Ido Y, Aoyagi K, Murabayashi S, Takebe K. Renal effects of nicardipine, a calcium entry blocker, in hypertensive type II diabetic patients with nephropathy. Diabetes. 1986;35:1206-1214.
26. Baba T, Boku A, Ishizaki T, Sone K, Takebe K. Renal effects of nicardipine in patients with mild-to-moderate essential hypertension. Am Heart J. 1986;111:552-557.
27. Eslami S, de Keizer NF, de Jonge E, Schultz MJ, Abu-Hanna A. A systematic review on quality indicators for tight glycaemic control in critically ill patients: need for an unambiguous indicator reference subset. Crit Care. 2008;12:R139.